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Training Instructions:
•

This document is to be used to train individuals in the position(s) indicated. If any items remain in this document that are no longer applicable, the
Trainer should mark them as “Not Applicable (NA)” and ask that this document be updated. Supplemental materials may need to be developed. The
quiz will be provided to the Trainer for administration.

•

The trainer should have knowledge of all areas covered in this document and be able to obtain additional resources if necessary. The trainer should have
a Master’s Degree or above, be a Certified IRB Professional (CIP) with IRB review, human subjects research, and administrative experience, having a
minimum of 4 years cumulative experience in human subjects research and/or IRB review.

•

Materials can be covered concurrently. And, to help with understanding, it would be best if information is not covered in isolation. For example, it might
be helpful to learn about the regulations as one reviews already approved protocols and learns what the workflow is within the office.

•

The material in the Level 1 should be covered before advancing to Level 2 If this is being used for re-training purposes, based on the individual’s
knowledge, experience and comfort level material may not be covered or not covered as thoroughly (as long as both the employee and trainer are
comfortable with the employee’s grasp of the topic/information).
For each item listed, both the employee and trainer must sign off. This ensures that there must be a dialogue between the employee and trainer. The
same is true for assessments. If there is a disagreement, or the trainer feels that the employee needs improvement, a plan for improvement must be
agreed to by both the employee and trainer and carried out within the specified timeframe.

•

•

The trainer is ultimately responsible for having all material covered and completes the Assessment portions of this document with the employee. The
trainer may ask others to assist in the process by covering material in this document with the employee, if /when that occurs the person who meets with
the employee initials in the area marked “met with” and the trainer verifies with the employee that he/she has not only covered the material but he/she
understands the material and needs no further instruction.

•

If training is delegated, it should be done by the Trainer to those selected should be established in their position and either be trained on how to present
the information to the new employee or already be performing job functions in accordance with current IRB internal procedures. Trainers are powerful,
select them wisely.

•

Trainees should be told that material in this document will need to be read many times over the course of their career in human subjects research and
protections.
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WASHINGTON UNIVERSITY EMPLOYEES
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OVERVIEW

OVERVIEW OPERATIONS

FIRST MORNING OF EMPLOYMENT
TO BE COMPLETED THE FIRST MORNING OF EMPLOYMENT-NEW EMPLOYEES – WITH THE MANAGER OF

•

Learns the University telephone exchanges: 935 (Danforth); 286, 362, 454, 747 (Medical School)

•

Learns the University website URLs: www. (used by Danforth); http:// (used by medical school)

•

Familiarizes oneself with the computer sign on and standard office software installed that will need to be used for the job function:
• Microsoft Office,
• Outlook for e-mails,
• Internet Explorer and Mozilla Firefox, etc.
• If any programs are unfamiliar or new employee is rusty, schedule a training session for given software or go to the CIT website
and print down the appropriate Quick Reference Guide. CIT website: http://citservices.wusm.wustl.edu/Pages/Welcome.aspx.
CIT HelpDesk for IRB is Central IT on the Medical School campus at 362-7798.

•

Name your computer. Open a Word document, go to the Office Button on the top left of your document, go to Word Options at the
bottom right of the pop-up screen, type in your name and initials under Personalize Your Copy of Microsoft.

•

Registers oneself for Research News, http://researchnews.wustl.edu, and selects, amongst other options, human subjects research to
receive notification.

•

Signs the IRB Assurance Form. (Copies are kept with New Member Training materials.)

•

Get acquainted with office:
• Office tour to locate supplies
• Ordering supplies
• Orientation to use of the copier/scanners
• Demonstration as to use of copier/scanners from Manager, Operations.
• Manager Operations, goes over Safety Plan,
• Manager Operations goes over how to access suite and building after hours.

•

Conference Room use
• Lunch
• Committee meetings
• Other meetings
• Scheduling on IRB conference room calendar
• Locking the doors
• Where key is kept.
• Clean-up
•

Schedule a session with Manager, Operations to go over general tools available to the office,

6|P a g e
2.5.13

IRB Analyst Training Manual

Employee

INITIALS
Met With

Date

TRAINER
VERIFIES

•
•
•
•
•

Access and use of office calendar
Access and use of the Conference Room calendar
Access and use of shared contact mailing lists
Location and use of IRB committee membership lists
Any other IRB inboxes needed

•

Review Use of Employee Self-Serve for time reporting and payroll (https://research.wustl.edu/Pages/ResearchGateway.aspx)

•

Go over the IRB Absence Request Procedure and Absence Request Form

•

Kitchen Etiquette:
• Use of the refrigerator, ice machine, microwave
• Cleaning up after oneself; no dirty dishes in the sink
• Office leftovers
• Marking your food
• Making and cleaning up the coffee and coffee pot
• Eating in the Conference Room –when this is possible; cleaning up after oneself
• Kitchen clean-up list
• Birthday treats list

•

Front Door
• No receptionist
• Answering when Deb Aumer is not available
• Ask for WU ID

•

IRB Suite Access
• Use of an access code or WU ID to enter suite
• Pass code for the alarm system
• Turning off your lights at night
• Opening the office if you are the first to arrive
• Turn on the lights
• Wake up the copiers by touching the screens
• Make a pot of coffee
• Closing the office when you are the last person to leave
• Turn off all the lights.
• Check all the doors to make certain they are locked
• Throw out any old coffee and turn off the coffee maker
• Copies go “to sleep” on their own
• Leave through the front door; set the alarm and leave through the doors

•

Maintenance Problems
• Report any maintenance problems to the Manager, Operations
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EMAIL AND PHONE OPERATIONS

TO BE COMPLETED THE FIRST MORNING OF EMPLOYMENT-NEW EMPLOYEES – WITH THE MANAGER OF

Go over e-mail account and usage. Set up E-mail signature line with: Signature (optional); name; title; office address; direct phone line; fax
number (see example below);

Sarah

Sarah Fowler-Dixon, PhD
Education Specialist
Washington University in St. Louis
Human Research Protection Office (IRB)
22 N. Euclid Ave., Ste. 233
St. Louis, MO 63108
314-633-7456
314-367-3041 (fax)
The materials in this email are private and may contain Protected Healthcare Information. If you are not the intended recipient, be advised
that any unauthorized use, disclosure, copying, distribution, or the taking of any action in reliance on the contents of this information is
strictly prohibited. If you have received this email in error, please immediately notify the sender via telephone or return mail.
Go over telephone use/etiquette/voicemail. Set up office voicemail and e-mail out of office e-mail notification using standard office language:
Primary phone message: “Hi, you have reached [name] in the Human Research Protection Office. I am either on the phone or away from my
desk. Please leave your name and number and I will return your call as soon as possible. Thank you.”
Alternate message: “Hi, you have reached [name] in the Human Research Protection Office. I am currently out of the office and will return on
[Monday, November 30]. Please leave your name and number and I will return your call as soon as possible. If you need immediate assistance,
please contact** [Deb Aumer at 633-7440]. Thank you.”
** [Your manager or designated person in the office during your absence; confirm with your manager and back-up person.]
Directions to change phone message:
Press “Message” on your phone
Enter password (passwords are reset to 1111); followed by #
8 – to change mailbox options
2 – to record or select personal greeting
1 – to record greeting
1 – for Primary or 2 – Alternate
Out of office e-mail: “Hi, I am currently out of the office until [December 28]. If you need immediate assistance, please contact **[Name of
Person at 633-XXX or e-mail address.]. Thank you.
** [Your manager or designated person in the office during your absence; confirm with your manager and back-up person.]
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Employee

INITIALS
Met With

Date

TRAINER
VERIFIES

OVERVIEW

OVERVIEW -

FIRST WEEK OF EMPLOYMENT
TO BE COMPLETED THE FIRST WEEK OF EMPLOYMENT-NEW EMPLOYEES – WITH THE MANAGER OF OPERATIONS

•

Attends Human Resources (HR) new employee orientation session. IRB Manager, Operations will assist in scheduling a session.
Date of Session Scheduled: _______________________

•

Reads/Reviews Employee Handbook, in particular policies pertaining to Equal Opportunity, Harassment, Abusive Conduct, Drugs
and Alcohol, Family Medical Leave Act, and inclement weather policy. Employee handbook can be found on the HR website at:
http://medschoolhr.wustl.edu/. Signs the Employee Handbook Acknowledgement Form that is placed in the employees HR file.

•

Parking information:
•
Obtain a parking location and/or U Pass information (http://parking.wustl.edu) with the assistance of the Manager,
Operations.
•
Learn about parking options on-campus and off-campus in the Central West End
•
If parking on-campus, complete the necessary paperwork to do a payroll deduction.
•
Learn about the WE CAR use
•
Identify the Office Parking Liaison who sends notices of road and parking closures
• Should have parking paperwork for on-campus parking.
•
Go over the IRB Parking Policy for parking in the lot under the building.

•

Reviews maps of the Medical School campus found at: http://www.wustl.edu/community/visitors/maps/index.html to familiarize
oneself with the campus and building names. Using the maps, locate the WUSTL Libraries, http://library.wustl.edu/, (Olin on
Danforth, Becker Memorial Library on Medical School, http://becker.wustl.edu/) and WUSTL Bookstores,
http://www.wustl.edu/about/campusstores/. The Athletic Complex is on Danforth. You may visit the library and bookstore on the
medical campus to see their exact location and reference to other facilities on campus.

•

Obtain Identification badge from the security desk outside Becker Medical Library. Hours of operation are Monday-Friday 9:00 am to
3:30 pm. From the Manager, Operations obtain the Washington University School of Medicine Identification/Access Control Request
(Badge) Form

•

Find out your Employee Identification Number (EMPLID): _______________________

•

Completes Environmental Health & Safety (EH &S) clerical/administrative training.

•

Reviews University Benefit information. New Benefit eligible employees must enroll within the first thirty-one (31) days of
employment eligibility. This is reviewed at HR orientation and can also be found on the HR website at:
http://medschoolhr.wustl.edu/ under Benefits.

•

Reviews Human Resources Professional Development opportunities: Learning and Development
(http://hr.wustl.edu/career_development/Pages/CourseCatalog.aspx), Tuition Assistance
(http://medschoolhr.wustl.edu/medadmin/hr/hrweb.nsf/WV/9362D0A1E6CC728986257218006CF024?OpenDocument), Computer
Training (http://becker.wustl.edu/classes/index.html).

9|P a g e
2.5.13

IRB Analyst Training Manual

Employee

INITIALS
Met With

Date

TRAINER
VERIFIES

•
•

Confirms TB Test – follow up with Employee Health
Greeted by Manager/trainer who will show him/her the assigned workspace, introduce new employee to other staff members, and
provide new employee with this Orientation/Competency checklist. Includes conversation on terms of employment (employment
program/orientation period/salary), work schedule & breaks/overtime, time and leave reporting/paydays, maintenance of accruals,
requesting time off, job duties and performance expectations, performance appraisals.

•

Schedule of meetings with Manager/trainer established to discuss progress and orientation/competency checklist items
•
Month one: Daily one-on-one meetings are established. Attendance at regular staff and team meetings mandatory.
•
Month two: Bi-weekly one-on-one meetings are established. Attendance at regular staff and team meetings mandatory.
•
Month three: Weekly one-on-one meetings are established. Attendance at regular staff and team meetings mandatory.
•
Month four and beyond: One-on-one meetings are scheduled as needed. Attendance at regular staff and team meetings
mandatory.

•

Meets with HRPO Executive Director to discuss function of the department, IRB organizational chart; IRB’s role within the WU
research enterprise; departmental mission, vision and goals; expected office decorum and professionalism. Included is a discussion of
how the IRB is perceived.

•

With your manager, go over the workflow charts.

•

Familiarizes oneself with the office shared folders and locates the IRB Reference Library (a file containing articles pertaining to human
subjects research topics).

•

Review material provided on the HRPO website, http://Hrpohome.wustl.edu and Vice Chancellor for Research website,
http://research.wustl.edu. Know what information is provided on each website and familiarize yourself with the various research
offices’ names and functions.

•

Reads and completes the University Code of Conduct found at:
http://universitycompliance.wustl.edu/codeofconduct/Pages/default.aspx

•

Completes mandatory HIPAA training assigned by HIPAA Liaison. (UserID, password, and location of training provided by Liaison.)

•

Contacts IT at 314-935-5707 to obtain WUSTL Key. (need EMPLID to develop WUSTL Key)

•

Schedule a one hour session with a myIRB administrator to go over myIRB administrative functions for your position, where to find
and/or store information, and system questions. Date session scheduled ______________________
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OVERVIEW MYIRB ELECTRONIC SUBMISSION TRAINING
OVERVIEW -

FIRST MONTH OF EMPLOYMENT

TO BE COMPLETED THE FIRST MONTH OF EMPLOYMENT-– WITH MYIRB ADMINISTRATOR

Employee

•

Attend myIRB training sessions. Register through the IRB website under myIRB.
•
New Project Training session date attended__________________
•
REF/Legacy Training session date attended _________________

•

In the trainees ‘draft folder, prepare a mock submission in myIRB to help familiarize you with the system. DO NOT SUBMIT.

OVERVIEW AND MYIRB COMPETENCY ASSESSMENT

OVERVIEW COMPETENCY ASSESSMENT - TRAINER COMPLETES WITH EMPLOYEE

NEEDS

IMPROVEMENT

Able to navigate the myIRB system
Familiar with office procedures
Adheres to IRB office procedures, e.g. absence requests, copier use, office hours, etc.
Able to use any required additional software needed for position, e.g. Microsoft Word, Outlook, Internet
Explorer, etc.
Able to understand and integrate new information, whether guidance, policy or office procedures into current
work flow, when needed
Is aware of and adheres to WU Human Resource policies.
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SATISFACTORY

INITIALS
Met With

Date

INITIALS
Employee
Trainer

TRAINER
VERIFIES

DATE

Non-IRB Offerings

Completed throughout the fiscal year

HUMAN RESEARCH PROTECTION PROGRAM TRAINING – NON-IRB OFFERINGS

OBJECTIVES ARE TO GET A FEEL FOR THE ENTIRE WU RESEARCH ENTERPRISE AND TO LEARN HOW OTHERS OUTSIDE THE OFFICE COMMUNICATE
WITH ONE ANOTHER.

Attends two to three free WU sessions, offered by offices other than IRB, that relate to some aspect of the submission, review, or conduct of human
subjects research, e.g. Grand Rounds, Brown Bag, PERCSS (RCR) session, Departmental specific offering (Biotech 21, Genomics, CIDER, ClinPortal
and caTissue, etc). Some of these sessions are advertised on Research News at http//researchnews.wustl.edu, some events are advertised on the
WU Medicine homepage at http:/medicine.wustl.edu, some in the Record that comes electronically, some on the Vice Chancellor for Research page
at http://research.wustl.edu under Resources, others can be found within departmental advertising. You can do a search for calendars of events on
the WU School of Medicine or Danforth campus websites.
Date and Name of Session:
Date and Name of Session:
Date and Name of Session:
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Employee

INITIALS
Trainer

Date

TRAINER
VERIFIES

LEVEL 1 TRAINING
HUMAN SUBJECTS ORIENTATION

Level 1 should be completed in the first 6 – 9 months of training
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Level 1 Human Subjects Foundation
First 2 weeks of employment

HUMAN SUBJECTS FOUNDATION THIS INFORMATION SHOULD BE READ BY THE TRAINEE SO THAT EVERYONE HAS SEEN THE FOUNDATION

MATERIAL. INITIALS AND DATE INDICATE THAT THE MATERIALS HAVE BEEN READ. CAN BE COMPLETED CONCURRENTLY WITH IRB REVIEWER ORIENTATION.

HOWEVER, THIS SECTION SHOULD BE COMPLETED IN THE FIRST 2 WEEKS OF EMPLOYMENT.
Completes IRB member level CITI training track. Access and directions found on the IRB homepage under CITI at http://Hrpohome.wustl.edu.
Learns the HHS Expedited and Exempt Categories.

On the OHRP website, read information pertaining to Federal Regulations, both HHS and FDA,
http://www.hhs.gov/ohrp/humansubjects/index.html
•
45 CFR 46
•
21 CFR 50
•
21 CFR 56
•
21 CFR 312/314
•
21 CFR 812/814
•
Read the IRB Policies and Procedures found under Policies on the IRB homepage at http://Hrpohome.wustl.edu
•

Read all IRB published guidelines found on the Guidelines page at http://Hrpohome.wustl.edu.

•

Read the following research policies on the Vice Chancellor for Research website at
http://research.wustl.edu/PoliciesGuidelines/Pages/WUSTLPoliciesGuidelines.aspx
- Clinical Trial Registration: Letter from the Vice Chancellor for Research to Faculty; Clinical Trial Registration FAQ
- Code of Conduct
- Environmental Health & Safety, Policies and Procedures
- HIPAA: Policy numbers 11 minimum necessary; 13 uses or disclosures of protected health information without verbal or written
authorization; 15 use of disclosure of protected health information in research; 17 security measures required to comply with privacy
policies
- Human Embryonic Stem Cell Research Guidelines
- Human Research Education Policy
- Human Research Participant Protection, Institutional Statement of Commitment
- Intellectual Property Policy
- Investigational Drug/Device Accountability Policy & Sample Logs

•

Read the Association for the Accreditation of Human Research Protection Programs (AAHRPP) Accreditation Standards at:
http://www.aahrpp.org/www.aspx?PageID=316.

•

Meet with Manager/Trainer to go over hierarchy of regulations, state statues, federal guidance, and institutional guidance. When does one
trump the other?
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INITIALS
Employee

Trainer

DATE

DATE
REREAD

Level 1 Assessment 1 Quiz

LEVEL 1 ASSESSMENT 1 - Satisfactory completion requires 70% or better on a quiz
Basic understanding of the following documents and their contents is tested
•
•
•
•
•
•
•

HHS Expedited and Exempt Categories.
45 CFR 46
21 CFR 50
21 CFR 56
21 CFR 312/314
21 CFR 812/814
IRB Policies and Procedures

•

IRB published guidelines found on the Guidelines

•

Vice Chancellor for Research policies
- Clinical Trial Registration: Letter from the Vice Chancellor for Research to Faculty; Clinical Trial Registration FAQ
- Code of Conduct
- Environmental Health & Safety, Policies and Procedures
- HIPAA: Policy numbers 11 minimum necessary; 13 uses or disclosures of protected health information without verbal or written authorization; 15 use of
disclosure of protected health information in research; 17 security measures required to comply with privacy policies
- Human Embryonic Stem Cell Research Guidelines
- Human Research Education Policy
- Human Research Participant Protection, Institutional Statement of Commitment
- Intellectual Property Policy
- Investigational Drug/Device Accountability Policy & Sample Log

ASSESSMENT – based on a passing score of 70%

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Level 1 – CRITERIA FOR REVIEW: RISKS, MONITORING

In some areas there is reference information that must first be read by the trainee before a study can be screened or reviewed to see how this
criterion is applied. This can be done as a class or in a group setting with standard mock studies. This can also be done in an intensive 3 week
training program. When screening or reviewing a study, the trainee should check off the areas covered. The number of studies that need to be
screened and reviewed depends on the issues in each study and the comfort level of the trainee. Once each area has been screen/reviewed the
respective criterion will be complete.
Risks are Minimized
•
Review the Assessing Risk Guideline on the IRB website under Biomedical Guidelines, Risk & Data Monitoring Guidelines at
http://Hrpohome.wustl.edu/study_team/guidelines.aspx
•
See myIRB Section VI (Participants) Section VII (Project Description) and Section VIII (Risks)
Risks are Reasonable
•
Read the Belmont Report found on the OHRP website at: http://www.hhs.gov/ohrp/humansubjects/index.html
•
Read the IRB Policies and Procedures on Unanticipated Problems found under Policies in the IRB website in the Policies and Procedures
document at http://Hrpohome.wustl.edu/study_team/policies.aspx
•
On the OHRP website, review “Reviewing and Reporting Unanticipated Problems Involving Risks to others and Adverse Events;
Withdrawal of Subjects from Research” at http://www.hhs.gov/ohrp/policy/investigators/index.html
•
See myIRB Section VIII (Risks) and Section IX (Benefits)
The research plan makes adequate provision for monitoring the data collected to ensure the safety of participants
•
On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html, review the guidelines found under For Investigators groups
documents that will be of particular interest to research investigators, such as how to handle subject withdrawal from a protocol, how to
assess unanticipated problems and adverse events that may occur during the conduct of research, and the general responsibilities of
research investigators
•
On the IRB website, under Risk & Data Monitoring Guidance, review the Data Monitoring guideline.
•
See myIRB Section VIII (Risks)
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Read
materials
that address
a given area

List studies
Screened
that address
each given
area

Date Reread
material

Level 1 Assessment 2 Quiz

LEVEL 1 ASSESSMENT 2 - Satisfactory completion requires 70% or better on a quiz
Understanding of the following elements of approvability are tested
•
Risks are Minimized
•
Risks are Reasonable
•
Provision for monitoring the data collected to ensure the safety of participants
ASSESSMENT – based on a passing score of 70%

NEEDS

SATISFACTORY

DATE

IMPROVEMENT

Level 1 – CRITERIA FOR REVIEW: AND PARTICIPANT SELECTION, RECRUITMENT
AND CONSENT
In some areas there is reference information that must first be read by the trainee before a study can be screened or reviewed to see how this
criterion is applied. This can be done as a class or in a group setting with standard mock studies. This can also be done in an intensive 3 week
training program. When screening or reviewing a study, the trainee should check off the areas covered. The number of studies that need to be
screened and reviewed depends on the issues in each study and the comfort level of the trainee. Once each area has been screen/reviewed the
respective criterion will be complete.
Participant Selection is Equitable
•
On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html review the guidelines found under the Vulnerable Populations
includes guidance addressing vulnerable groups such as children, prisoners, and subjects for whom a certificate of confidentiality may
offer appropriate additional protections
•
Review 45 CFR 46, subparts B, C, and D http://www.hhs.gov/ohrp/humansubjects/index.html
•
Review 21 CFR 50 subpart D http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=50&showFR=1
•
See myIRB Section VI (Participants) and Section VII.D (Recruitment and Consent)
Recruitment methods are fair, appropriate, and designed to allow to ensure equitable selection of subjects
•
Review the FDA Recruiting Study Subjects – Information Sheet at
http://www.fda.gov/RegulatoryInformation/Guidances/ucm126428.htm
•
Review OHRP guidance Research Participants – Employees in the Workplace
With your manager, discuss the following Recruitment issues:
•
What does the IRB need to see
•
What should be in an advertisement; what is an acceptable ad
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Read
materials
that address
a given area

List studies
Screened
that address
each given
area

Date Reread
material

•
Use of SS# to recruit or follow-up
•
Use of Facebook and such
•
Use of commercial groups to recruit
Recruitment vs. engagement in the study
Payment arrangements are fair, honest, and appropriately designed to allow for the equitable selection of participants and to fulfill the regulatory
requirements for consent
•

On the FDA website, review Payment to Research Subjects – information sheet
athttp://www.fda.gov/RegulatoryInformation/Guidances/ucm122046.htm

The Consent Process provides sufficient protections to participants such that additional oversight is not required.
•
On the IRB website review Guidelines listed under Vulnerable Populations: Third Party Consent Guidelines, Vulnerable Population –
Healthy, Students, and Employees, and Wards of the State.
•

On the IRB website review the Subject Pools guidance for Olin School of Business and Psychology Department.

•

On the IRB website review the Legal Age to Consent (outside of Missouri) guideline

•

See myIRB Sections VI (Participants) and Section VII.D (Recruitment and Consent)

For HHS-supported multicenter clinical trials, the IRB should receive and review a copy of the HHS-approved sample informed consent
document(s) and the complete HHS-approved protocol, if they exist.
•
Only pertains to NIH studies where a sample consent is provided.
•
With the assistance of your manager, locate a study that has a sample consent form to review.
•
Review OHRP “Guidance on Written IRB Procedures” http://www.hhs.gov/ohrp/policy/irbgd107.html
•
Review the CTEP, DCTD and NCI Investigator’s Handbook for Cancer research regarding this topic found under 7.3 Informed Consent
on page 45 at http://ctep.cancer.gov/investigatorResources/docs/InvestigatorHandbook.pdf which states “Individual institutions may
make minor changes to model informed consent forms. However, the informed consent document’s originator must approve any changes
in risks or alternative procedures.”
•
Review OHRP guidance “Institutional Review Board of Protocol and Informed Consent Changes” found on the OHRP website at:
http://www.hhs.gov/ohrp/policy/consent/nci200870929.html
•
Read and familiarize yourself the WU myIRB consent template found within the myIRB system.
Informed consent will be sought from each prospective subject or the subject’s legally authorized representative (LAR)
•

On the IRB website, review the Consent Guidance and Missouri Statutes included in that guidance document.

•

On the IRB website, review the, taxable income and waiver of consent guidelines.

•

On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html, review the Informed Consent groups documents that address
autonomy and consent issues.

•

See myIRB Sections VII.D (Recruitment and Consent), Secdtion IV.2-19 (Waiver of Consent and Waiver of Elements of Consent), Section
VII.D16 (Waiver of Documentation of Consent)

Is it appropriate to allow the inclusion of adult subjects who do not have the ability to consent for themselves?
•
On the IRB website review Guidelines listed under Vulnerable Populations: Cognitive Impairment
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•
•

On the IRB website, review the Assent guideline
See myIRB Sections VI.25 – VI.31 (Decisionally impaired participants) and VII.D (Recruitment and Consent)

Informed Consent will be appropriately documented.
•
Review the OHRP Informed Consent Checklist at: http://www.hhs.gov/ohrp/policy/consentckls.html
•
See myIRB Sections VII.D (Recruitment and Consent), IV. 3 (Waiver of Informed Consent or Waiver of Authorization), VII.D16 (Waiver of
Documentation of Consent)
With your manager discuss the following Consent issues:
•
Non English speaking populations and consent
•
Short form consent and its use
•
Alteration or elimination of consent elements
•
Mandatory vs. optional elements of consent, when
•
Debriefing documents, when appropriate
•
Appropriate consent language
•
Collection of SS# when payments are made to research participants

Level 1 Assessment 3 Quiz

LEVEL 1 ASSESSMENT 3 - Satisfactory completion requires 70% or better on a quiz

Understanding of the following elements of approvability are tested
•
Participant selection is equitable
•
Recruitment methods are fair, appropriate, and designed to allow to ensure equitable selection of subjects
•
Payment arrangements are fair, honest, and appropriately designed
•
Consent Process provides sufficient protections to participants such that additional oversight is not required
•
Information provided in the WU consent document is consistent with the DHHS approved sample consent document
•
Informed consent will be sought from each prospective subject or the subject’s legally authorized representative (LAR)
•
Is it appropriate to allow the inclusion of adult subjects who do not have the ability to consent for themselves?
•
Informed Consent will be appropriately documented.
ASSESSMENT – based on a passing score of 70%

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Level 1 – CRITERIA FOR REVIEW: PRIVACY, CONFIDENTIALITY, VULNERABLE
POPULATIONS

In some areas there is reference information that must first be read by the trainee before a study can be screened or reviewed to see how this
criterion is applied. This can be done as a class or in a group setting with standard mock studies. This can also be done in an intensive 3 week
training program. When screening or reviewing a study, the trainee should check off the areas covered. The number of studies that need to be
screened and reviewed depends on the issues in each study and the comfort level of the trainee. Once each area has been screen/reviewed the
respective criterion will be complete.
There are adequate provisions to protect the privacy interests of participants.
•
Review the IRB guidance on Guidelines for reviewing studies involving genetic research.
•
See myIRB Sections X (Privacy and Confidentiality), Section VII.C (Genetic Research) and Section XII (Future Research)

There are adequate provisions to maintain the confidentiality of data.
•
Read HI-TECH addition to the HIPAA Regulations found on the HHS website at:
http://www.hhs.gov/ocr/privacy/hipaa/administrative/enforcementrule/hitechenforcementifr.html
•
Review the Confidentiality Guidelines on the IRB website under Confidentiality guidelines: Certificate of Confidentiality, Maintenance of
Confidentiality, NIH Certificate of Confidentiality Guideline & Other Information, FDA application
•
Computer Security
• Who is responsible
• What is needed to satisfy IRB review
• Who to contact with questions – WU HIPAA Security Officer
• Which databases/systems are considered secure and WU approved for use: RedCap, secure USB drives issued by HIPAA security
liaisons; secure FTP maintained by the School of Business, SharePoint sites, BJC, SLCH, and WU e-mails, sites behind WU firewalls,
SurveyMonkey (although information may be identifiable if obtained through SurveyMonkey).
• Non-secure devices include Android phones; IPads; The Cloud; Google
• Review Laptop Security, Encryption Security, Polices and Procedures at Network Security Office homepage:
http://nso.wustl.edu/Services/Pages/default.aspx
•
See myIRB Sections X (Privacy and Confidentiality), Section VII.C (Genetic Research) and Section XII (Future Research)
When some or all of the participants are likely to be vulnerable to coercion or undue influence, such as children, prisoners, or pregnant women,
additional safeguards have been included in the study to protect the rights and welfare of these participants.
•
See myIRB Sections VI (Participants) and VII.D (Recruitment and Consent)
With your manager, discuss the types of Populations seen at WU:
•
Healthy volunteers
•
Those with the condition under study
•
Not healthy but not with the condition under study
•
Students
•
Employees
•
Decisionally impaired
•
Terminally ill
•
Critically ill
•
Minors
•
Emancipated Minors
•
Wards of the State
20 | P a g e
2.5.13

IRB Analyst Training Manual

Read
materials
that address
a given area

List studies
Screened
that address
each given
area

Date Reread
material

Level 1 Assessment 4 Quiz

LEVEL 1 ASSESSMENT 4 - Satisfactory completion requires 70% or better on a quiz

Understanding of the following elements of approvability are tested
•
Provisions to protect the privacy interests of participants
•
Adequate provisions to maintain the confidentiality of data
•
When some or all of the participants are likely to be vulnerable to coercion or undue influence, such as children, prisoners, or pregnant women, additional
safeguards have been included in the study to protect the rights and welfare of these participants
ASSESSMENT – based on a passing score of 70%

NEEDS

SATISFACTORY

DATE

IMPROVEMENT

Level 1 – FDA: IND, IDE AND THE DIFFERENCE BETWEEN HHS AND FDA
REGULATIONS
In some areas there is reference information that must first be read by the trainee before a study can be screened or reviewed to see how this
criterion is applied. This can be done as a class or in a group setting with standard mock studies. This can also be done in an intensive 3 week
training program. When screening or reviewing a study, the trainee should check off the areas covered. The number of studies that need to be
screened and reviewed depends on the issues in each study and the comfort level of the trainee. Once each area has been screen/reviewed the
respective criterion will be complete.
IND Determination
•
See myIRB Section VII.B 1 – 8

On the FDA website, read information pertaining to investigational drugs and devices,
http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/InvestigationalNewDrugINDorDeviceExemptionIDEProcess/defaul
t.htm
•

•
•

FDA Investigational New Drug application information:
http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/InvestigationalNewDrugINDorDeviceExemptionIDEProc
ess/ucm094309.htm
Investigational New Drug number required vs. not
Review the FDA Combined products guidance documents: http://www.fda.gov/RegulatoryInformation/Guidances/ucm122047.htm
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Read
materials
that address
a given area

List studies
Screened
that address
each given
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Date Reread
material

IDE Determination
•

See myIRB Section VII.B 20-26

On the FDA website, read information pertaining to investigational drugs and devices,
http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/InvestigationalNewDrugINDorDeviceExemptionIDEProcess/defaul
t.htm
•

•
•

FDA Investigational Device Exemption information:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/
default.htm
- Definitions and Acronyms; Approval Process; Responsibilities; Application; Reports; IRB: Informed Consent; Financial
Disclosure;
Early/Expanded Access; Enforcement of Good Clinical Practice Regulations; Import/Export of Investigational devices; FAQ
about IDE; IDE related topics; IDE guidance
Significant vs. Non-significant Risk Devices vs. Exempt Devices
General Device Advice FDA page is:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080202.htm

Difference between HHS and FDA regulations
•
•
•
•

Re-read 45 CFR 46 with all its subparts
Re-read 21 CFR 50 with its subparts
Review the chart that outlines the differences between FDA and HHS regulations found on the FDA website at
http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/educationalmaterials/ucm112910.htm.
Discuss the difference and the application of each regulation your train/manager.

Level 1 Assessment 5 Quiz

LEVEL 1 ASSESSMENT 5 - Satisfactory completion requires 70% or better on a quiz
Understanding of the following elements of approvability are tested
•
IND determinations
•
21 CFR 312 and 21 CFR 314
•
IDE determinations
•
21 CFR 812 and 21 CFR 814
ASSESSMENT – based on a passing score of 70%

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Level 1 – OTHER REVIEW CONSIDERATIONS: CONFLICT OF INTEREST, MULTI-SITE
RESEARCH, GRANT, RESEARCH DESIGN AND ASSURANCE
In some areas there is reference information that must first be read by the trainee before a study can be screened or reviewed to see how this
criterion is applied. This can be done as a class or in a group setting with standard mock studies. This can also be done in an intensive 3 week
training program. When screening or reviewing a study, the trainee should check off the areas covered. The number of studies that need to be
screened and reviewed depends on the issues in each study and the comfort level of the trainee. Once each area has been screen/reviewed the
respective criterion will be complete.
Conflict of Interest
•
Read the Conflicts of Interest: Conflict of Interest Policy; Conflict of Interest and Clinical Research Policy
on the Vice Chancellor for Research website at http://research.wustl.edu/PoliciesGuidelines/Pages/WUSTLPoliciesGuidelines.aspx
•
Review the Personal Conflict of Interest guideline on the IRB website under
http://Hrpohome.wustl.edu/reviewers/reviewing_guidance.aspx
•
On the OHRP website under Investigators review the Financial Conflict of Interest Policy from HHS at
http://www.hhs.gov/ohrp/policy/index.html.

The study has an adequate plan to manage information and communication for multi-site research when WU is the lead site or provides study-wide
services.
•
On the OHRP website, review IRBs and Assurances at: http://www.hhs.gov/ohrp/assurances/index.html
•
On the IRB website under Community Engaged Research (CEnR) Program, under WU Researchers, review Obtaining and Assurance and
Requesting WU as the IRB of Record.
•
See myIRB Section VIIA 10-17 (Basic Project Information)
If the study is funded by NIH or another federal agency, and WU is the prime awardee site, is the grant consistent with the protocol?
With your manager go over the following to determine what it is, when it is used, and what IRB/IRB does with the document, if anything.
•
Grant –
• In addition to the above questions, review the various grant mechanisms on the NIH website at:
http://grants.nih.gov/grants/funding/funding_program.htm
• Of those listed on a grant who is considered engaged in human subjects research and needs to be listed on IRB submissions
•
Contract
•
Subcontract
•
Gift
•
Fee for Service
The Research Design has Scientific or Scholarly Validity
•

On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html review the guidance listed under Protocol Review groups
information addressing the categories and criteria for approval of human subjects research under the HHS regulations, including
guidance on exempt and expedited review determinations and continuing review.

•

On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html review the guidance listed under Checklists & Decision Trees
groups decision charts and checklists that have been developed for the IRB community.

•

On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html review the guidance listed under Biological Materials & Data
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groups OHRP's guidance addressing issues such as research using human subjects data and biological samples, and application of the
Genetic Information Nondiscrimination Act (GINA) in research.
•

Read the Declaration of Helsinki (World Medical Association www.wma.net, specific URL:
http://www.wma.net/en/20activities/10ethics/10helsinki/)

•

Read the Nuremberg Code (Office of Human Subjects Protection, http://ohsr.od.nih.gov/guidelines/nuremberg.html)

•

On the IRB website, review the Local Research Review (outside of the US)

•

Read basic information about study designs: http://hsl.lib.umn.edu/biomed/help/understanding-research-study-designs;
http://galton.uchicago.edu/~thisted/courses/315/lectures/0297.pdf

See myIRB Section I.7, I.8 (Project Summary and Research Question), Section VII.E (Methods), IX.2 (Benefits to Society) and XI. (Data
Analysis)
Assurances
•

•

On the OHRP website, http://www.hhs.gov/ohrp/policy/index.html, review the guidelines pertaining to Institutional Issues groups
documents that will be of particular concern to institutions, such as management of an IRB and conduct of IRB meetings, determination of
institutional-level engagement in human subjects research, and institutional reporting requirements.

•

On the OHRP website, http://www.hhs.gov/ohrp/assurances/index.html, read information about Assurances (FWA, IIA, IAA)

•

With your manager, discuss Engagement in a research study
•
OHRP guidance on engagement
•
Federalwide Assurance
•
Individual Investigator Agreement
•
IRB authorization Agreement
•
Individual Volunteer Agreement
•
WU-SLU umbrella agreement
•
Human subjects education needed
•
HIPAA training/implications
•
Letter of agreement vs. Code access agreement vs. e-mail of agreement
•
Data use agreement – what is this and when does this change engagement in the study?
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Level 1 Assessment 6 Quiz

LEVEL 1 ASSESSMENT 6 - Satisfactory completion requires 70% or better on a quiz

Understanding of the following elements of approvability are tested
•
Conflict of interest
•
Adequate plan to manage information and communication for multi-site research when WU is the lead site or provides study-wide services
•
Grants and other funding mechanisms
•
Research Design has Scientific or Scholarly Validity
•
Assurances
ASSESSMENT – based on a passing score of 70%

NEEDS

SATISFACTORY

DATE

IMPROVEMENT

Level 1 REVIEWER FORMS

REVIEWER FORMS – TRAINEE SHOULD GO OVER THE REVIEWER FORMS TO FAMILIARIZE HIM/HERSELF WITH THE FORMS AND WHAT IS INCLUDED
IN EACH.

After completing the Criteria for Review, go over the Reviewer Forms to see how they would be used in conjunction with the Criteria and with
studies under review. Discuss any questions with the trainer.
•
New Protocol Submission
•
Continuing Review Submission
•
Modifications
•
Unanticipated Problem
•
Pregnant women
•
Neonates (non-viable or of uncertain viability)
•
Children
•
Prisoners
•
Deception
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LEVEL 2
APPLICATION OF INFORMATION TO IRB ANALYST DUTIES
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Level 2 Procedure Overview

PROCEDURE OVERVIEW – THIS IS TO ORIENT YOU TO THE SPECIFIC PROCEDURES YOU WILL USE AS AN ANALYST.
•

The trainee will review the procedure outline located here: G:\Policies and Procedures\Procedures
Date completed:

•

The trainee will meet with the trainer to discuss and answer questions.

Employee

INITIALS
Met With

Date

TRAINER
VERIFIES

Date

TRAINER
VERIFIES

Level 2 myIRB Electronic Application Guide and Screening

SCREENING AND MYIRB APPLICATION GUIDE TRAINING – THIS IS TO ORIENT YOU TO THE SCREENING PROCESS AND USE OF

THE MYIRB APPLICATION GUIDE

•

THE EXPECTED TIMELINE FOR REACHING PLACEMENT INTO ROTATION (STEP 3) ON ALL SUBMISSIONS IS 6 MONTHS.
The trainer will review purpose and goals of the myIRB application guide with the trainee.

•

The trainer and trainee will step through the screening process of a recently approved, pre-selected study or a mock study
specifically designed for training purposes.

•

The trainee will read through 20 recently approved studies to get a feel for the screening process and workflow from receipt until
approval. Once complete meet with trainer to discuss questions. Date Completed:
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Employee

INITIALS
Met With

Level 2 Contingency Training

CONTINGENCY TRAINING– THIS IS TO ORIENT YOU TO THE SCREENING PROCESS AND USE OF THE MYIRB APPLICATION GUIDE

AS TOOLS TO DETERMINE STUDY CONTINGENCIES SENT IN

PREPARING A STUDY TO BE SCHEDULED FOR FULL BOARD REVIEW.

•

New Studies:
-Step 1-The trainee will be assigned studies for screening in conjunction with the trainer. Volume will be determined by the trainer. The trainer and the trainee will screen the study
separately then review together before sending out contingencies. Responses will be reviewed with the trainer to determine if any additional information is requested. Once complete
the study will be routed for scheduling.
-Step 2-The trainee will be placed in the rotation for new studies. Prior to sending questions to the researcher the trainee and trainer will discuss the study and review questions to
make sure all issues have been identified. Responses will be reviewed with the trainer as needed based on complexity.

•

Modifications
-Step 1-The trainer and trainee will screen a modification together reviewing the key points to consider when screening modifications.
Step 2-The trainee will screen the modification and then meet with the trainer to review questions prior to sending to research team. If there are not questions, the trainee will meet
with trainee to review the modification to prior to sending for scheduling.

•

Continuing Reviews and Modification/CRs
-Step 1-The trainer and trainee will screen a continuing review together looking at the key points to consider during the screening process.
Step 2 -The trainee will screen the continuing review and then meet with the trainer to review questions prior to sending to the research team. If there are no questions, the trainee
will meet with the trainee to review the continuing review to prior to sending for scheduling.

•

Reportable Events
-Step 1-The trainer and trainee will screen a reportable event together looking at the key points to consider during the screening process.

-

Step 2-The trainee will screen the reportable event and then meet with the trainer to review questions prior to sending to research team. If there are no questions, the trainee will meet
with trainee to review the reportable event prior to sending for scheduling.

Level 2 Assessment 1 Mock Protocol

A MOCK OR PRE-SELECTED PROTOCOL IS USED TO ASSESS THE ANALYST’S ABILITIES.
ASSESSMENT

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Levels 2 Placed into Rotation

SCREENING, MYIRB APPLICATION GUIDE, AND CONTINGENCY TRAINING – Once Step 3

is reached the trainee will be placed into rotation

•

New Studies:- Step 3-The trainee will remain in the rotation and trainer will be available for questions as needed.

•

Modifications: Step 3-The trainee will screen modifications and trainer is available for questions as needed.

•

Continuing Reviews and Modification/CRs: Step 3-The trainee will screen continuing reviews and trainer is available for questions as needed.

•

Reportable Events: Step 3-The trainee will screen reportable events and trainer is available for questions as needed.

AREA NEEDING IMPROVEMENT (SPECIFY)

Level 2 Assessment 2 Placed into Rotation
PLAN FOR IMPROVEMENT

DEADLINE

NOT

SATISFACTORY

SATISFACTORY

Level 2 Meeting Dynamics

MEETING DYNAMICS – THIS IS TO ORIENT THE TRAINEE TO VARIOUS COMMITTEE PERSONALITY AS WELL AS SET-UP AND TEAR-DOWN OF THE
COMMITTEE MEETINGS

•

Attend a New Member Training session

•

Observe 2 – 3 committee meetings just to see how the members interact with one another
• Note what the IRB Chair for the meeting does or does not do.
• Note what the Administrative Representative does or does not do.

•

Discuss meeting dynamics with your Manager/trainer, Coordinator for that meeting, and possibly the Executive Chair.

•

Review Meeting Set-up and Tear-down with your Manager/trainer.
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INITIALS
Employee

Meeting Observed

Trainer

DATE

Discussed with
Manager/trainer or
other

Level 2 Minutes Training

MINUTES TRAINING – THIS TRAINING WILL INVOLVE FAMILIARIZATION WITH THE PROCEDURES FOR CREATING, TAKING AND DISSEMINATING

MINUTES, ALONG WITH ONE-ON-ONE EXPERIENCE WRITING MINUTES FOR ACTUAL STUDIES BEING REVIEWED. THIS TRAINEE CAN BE THE THIRD
NOTETAKER, COMPARING NOTES TO THOSE BEING TAKEN FOR THE MEETING.

Employee

THE TRAINEE WILL BE PLACED INTO THE ROTATION FOR COMMITTEE

INITIALS
Met
With

Date

TRAINER
VERIFIES

COVERAGE NO SOONER THAN 6 MONTHS AFTER THE START OF EMPLOYMENT.

•

Review procedures for minutes that includes:
•
How to create pre-minutes
•
Taking minutes during the meetings
•
Creating minutes after the meeting and sending to the researcher
•
Sending final minutes to the committee

•

Attends full board meetings for one month to take notes and listen to discussion
•
Dates of meeting attended:

•

Goes over any issues/questions that arise at the meeting with the Trainer
•
Dates of meeting for which questions arose:

•

Reviews the minutes from the meetings observed. Directs any questions to the Trainer.
•
Dates for which minutes were reviewed:

•

Develops unofficial minutes to the meetings which are reviewed by the Trainer
•
Dates of meeting for which unofficial minutes developed:

•

Develops official minutes to the meetings attended.
•
Dates of meetings for which official minutes developed:

AREA NEEDING IMPROVEMENT (SPECIFY)

Level 2 Assessment 3 Minutes Training
PLAN FOR IMPROVEMENT

DEADLINE

NOT

SATISFACTORY
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SATISFACTORY

INITIALS
Employee

Trainer

DATE

Level 2 Lead Analyst Training

LEAD ANALYST TRAINING – THIS IS TO ORIENT YOU TO THE SPECIFIC DUTIES OF THE LEAD ANALYST FOR A
•

COMMITTEE MEETINGS

The trainer will review the responsibilities of the lead analyst with the trainee. These responsibilities can be found within the PreMeeting Prep procedure.

AREA NEEDING IMPROVEMENT (SPECIFY)

Level 2 Assessment 4 Lead Analyst duties
PLAN FOR IMPROVEMENT

DEADLINE

NOT

SATISFACTORY
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Employee

SATISFACTORY

INITIALS
Met With

INITIALS
Employee

Date

Trainer

TRAINER
VERIFIES

DATE

LEVEL 3 INTERMEDIATE TRAINING
TO BE COMPLETED AFTER THE FIRST 9 MONTHS OF EMPLOYMENT UP TO 48 MONTHS OF EMPLOYMENT.
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Level 3 Community Engaged Research, International Studies, Psychology
Employee

INITIALS
Trainer

Community Engaged Research Studies, include St. Louis Community/ University Health Research Partnership grant
background/information, IRB process for handling CEnR studies, FWA/IIA/IAA issues, human subjects education training issues, engagement
of sites, methodology used, various types of CEnR studies such as HealthStreet, WU PAARC. IRB numbers: _____________________________
Review and discuss an International Study including consent, translated consents, qualified translators, local context review, ethics
committee/government approvals
Embargos, international FWAs. IRB number: _____________________________
Psychology protocol, include consent document, debriefing documents, protocol/submission, Experimetrix, psychology pool information,
terminology, coercion/undue influence and how handled, recruitment methods. IRB number: __________________________

Level 3 Assessment 1 Mock Protocol

A MOCK OR PRE-SELECTED PROTOCOL IS USED TO ASSESS THE ANALYST’S ABILITIES.
ASSESSMENT

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Date

Level 3 Industry Sponsored, NCI Cooperative Group, CIRB Reviewed
Review and discuss an Industry sponsored protocol, include investigator’s brochure, device pamphlet, consent document, protocol, MedWatch
reporting document., terminology, FDA regulation and what that means, reporting requirements, IRB number:
_____________________________

Employee

INITIALS
Trainer

Review and discuss a NCI cooperative group protocol include sample NIH consent document, protocol, reporting requirements, toxicity
requirements for determining adverse/serious adverse events, notifications, how cooperative groups function, funding mechanisms. IRB
number: ____________________________
CIRB reviewed studies, what this means, what is looked for, what is CIRB and how it can be used. https://www.ncicirb.org/

Level 3 Assessment 2 Mock Protocol

A MOCK OR PRE-SELECTED PROTOCOL IS USED TO ASSESS THE ANALYST’S ABILITIES.
ASSESSMENT

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Date

Level 3 Humanitarian Use Device, Emergency Use, Single Patient Treatment
Review and discuss a Humanitarian Use Device study, what are they, why are they reviewed by the IRB, what should be submitted for review,
what types of consent are acceptable, when does a HUD become an investigational device and need an investigational device exemption, how to
make modifications to a HUD. Discuss off-label use of the HUD. HUD information is available from the FDA at:
http://www.fda.gov/downloads/ForIndustry/DevelopingProductsforRareDiseasesConditions/DesignatingHumanitarianUseDevicesHUDS/
UCM283504.pdf

Employee

INITIALS
Trainer

IRB number: ____________________________
Review and discuss the Emergency Use of an investigational drug or device. Review IRB procedures. FDA information can be found at:
http://www.fda.gov/RegulatoryInformation/Guidances/ucm126491.htm.
Review and discuss Single Patient Treatment with an Investigational Drug or Device. FDA information can be found at:
http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/InvestigationalDeviceExemptionIDE/ucm05
1345.htm

Level 3 Assessment 3 Mock Protocol

A MOCK OR PRE-SELECTED PROTOCOL IS USED TO ASSESS THE ANALYST’S ABILITIES.
ASSESSMENT

NEEDS
IMPROVEMENT
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SATISFACTORY

DATE

Date

DATE REREAD

Level 3 Genomics or GWAS, Non-Human Subjects Activities and Not Engaged
Review and Discuss a Genomics or GWAS study. Review a brief guide to Genomics from the National Human Genome Research Institute at
http://www.genome.gov/18016863. Review IRB guidelines and procedures

Employee

INITIALS
Trainer

Review Non-Human Subjects and Not Engaged activities that come into the IRB.
•
Read the OHRP Guidance on Engagement: http://www.hhs.gov/ohrp/policy/engage08.html
•

Read the NIH Decision Trees: http://www.hhs.gov/ohrp/policy/checklists/decisioncharts.html

•

Case studies/case reports. On the HRPO website under Guidance at
http://Hrpohome.wustl.edu/study_team/guidelines/casestudyguideline.rtf

•

Training Grants

•

Overall approvals

•

Quality assurance projects

•

Program evaluations

Level 3 Assessment 4 Mock Protocol

A MOCK OR PRE-SELECTED PROTOCOL IS USED TO ASSESS THE ANALYST’S ABILITIES.
ASSESSMENT

NEEDS
IMPROVEMENT
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Level 3 Distinguish the Difference,
Department of Education and Department of Defense
Employee
Distinguishing the Difference. You should already be familiar with the terms below. If not, take time to review each term. Once you have learned
the definition and use for each term, it is time to learn how they are different from one another and to learn which the clinical terms are and which
the research terms are. As these terms are often interchanged but have different meanings, the goal is to tell them apart, know when a submitter is
really referring to the research term and what that research term entails. A discussion regarding each should take place with the Manager/Trainer
•
Source Document vs. IRB submission material
•
Clinical chart/record/document vs. Research chart/record/document
•
Clinical consent vs. Research consent
•
HIPAA training vs. Human Subjects Research Training vs. Responsible Conduct of Research Training vs. Environmental Health and
Safety Training
•
Clinical terminology vs. Regulatory/research terminology
•
Investigator’s point of view vs. IRB point of view
•
Research participant vs. third party vs. no third party vs proxy consent
•
Exempt 2 vs. Expedited 7
•
Exempt 4 vs. Expedited 5
•
PI collects data/specimens vs. wants access to data specimens and was collaborator vs. wants access and was not collaborator
•
Wavier of consent vs. Waiver of authorization vs. partial waiver of authorization
•
Non human vs. human subjects research vs. exempt
•
Modification vs new study
•
Expedited review vs. referral to full board
•
New study is needed vs a modification to an existing study
•
QA/QI vs Research
Department of Education (DoE) regulations relevant to human subjects research. http://www2.ed.gov/policy/fund/reg/edgarReg/edgar.pdf
•
Education Department General Administrative Regulations (EDGAR) 34 CFR Parts 76 (Participation of Students Enrolled in Private
Schools); 97 (Protection of Human Subjects); 98 (Student Rights in Research, Experimental Programs and Testing); 99 (Family Educational
Rights and Privacy),
•
Family Educational Rights and Privacy Act (FERPA); http://www2.ed.gov/policy/gen/guid/fpco/ferpa/index.html
•
Protection of Pupil Rights Amendment (PPRA), http://www2.ed.gov/policy/gen/guid/fpco/ppra/index.html
Department of Defense (DoD) regulations relevant to human subjects research
•
DoD and OUSD ( P &R) Specific and Unique Requirements, http://fhp.osd.mil/pdfs/HRPP_laws_regulations_policies.pdf
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Level 3 Assessment 7 Quiz

LEVEL 3 ASSESSMENT 4 - Satisfactory completion requires 70% or better on a quiz
•

Understanding of the following and being able to distinguish between the two often confused items:
•
Source Document vs. IRB submission material
•
Clinical chart/record/document vs. Research chart/record/document
•
Clinical consent vs. Research consent
•
HIPAA training vs. Human Subjects Research Training vs. Responsible Conduct of Research Training vs. Environmental Health and Safety Training
•
Clinical terminology vs. Regulatory/research terminology
•
Investigator’s point of view vs. IRB point of view
•
Research participant vs. third party vs. no third party vs proxy consent
•
Exempt 2 vs. Expedited 7
•
Exempt 4 vs. Expedited 5
•
PI collects data/specimens vs. wants access to data specimens and was collaborator vs. wants access and was not collaborator
•
Wavier of consent vs. Waiver of authorization vs. partial waiver of authorization
•
Non human vs. human subjects research vs. exempt
•
Modification vs new study
•
Expedited review vs. referral to full board
•
New study is needed vs a modification to an existing study
•
QA/QI vs Research

•
•
•
•

34 CFR Part 76
Family Educational Rights and Privacy Act (FERPA)
Protection of Pupil Rights Amendment (PPRA
DoD and OUSD ( P &R) Specific and Unique Requirements

ASSESSMENT – based on a passing score of 70%

NEEDS
IMPROVEMENT
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Level 3 Social Media, HIPAA Issues, How WU HRPP Works Together
Employee

Uses of Social Media for research purposes
•
Read the Washington University Social Media Guidelines issued by Medial Public Affairs at:
http://medschool.wustl.edu/policies/social_media_guidelines
HIPAA Issues
•
Business Associate Agreement – who handles this?
•
Data Use agreement
•
What is the covered entity at WU?
•
When does HIPAA apply to a study?
•
Can parts of a study be HIPAA governed and others not? E.g. Departments that live in and out of covered entity: Social Work, Institute for
Public Health, Surgery
•
How to know that the hardware/software proposed in a study for data collection is HIPAA compliant, if applicable.
What are the various research offices at WU and how do they work together?

Level 3 Assessment 8 Quiz

LEVEL 3 ASSESSMENT 5 - Satisfactory completion requires 70% or better on a quiz
Understanding of the following as it pertains to human subjects research
•
WU Social Media guideline
•
HIPAA Issues
•
How the WU Human Research Protection Program (HRPP) works together.
ASSESSMENT – based on a passing score of 70%

NEEDS
IMPROVEMENT
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Level 3 On-Call: questions by phone

ANSWERING GENERAL QUESTIONS BY PHONE (ON-CALL) - INITIALS AND DATE INDICATE THAT DISCUSSION HAS TAKEN
PLACE.

•

Step 1 - Phone calls taken with Manager/Trainer (within first month of hire)

•

Step 2 - Phone calls taken with direction from Manager/Trainer based on comfort level/knowledge of employee (should begin no
later than second month of hire)

•

Step 3 - Phone calls taken independently. Employee may refer to Manager/Trainer if he/she has questions or needs assistance.
(should begin no later than third month of hire)

Employee

INITIALS
Trainer

Date

Employee

INITIALS
Trainer

Date

Level 3 SWAT: office hours

ANSWERING QUESTIONS FOR GENERAL QUESTIONS – OFFICE HOURS AND SWAT- INITIALS AND DATE INDICATE
THAT DISCUSSION HAS TAKEN PLACE.

•

Read all HRPO/IRB Guidance Documents on the website and/or all At-A-Glance documents, if available.

•

Step 1: Face-to-face meeting with investigators done in conjunction with Manager/Trainer (within first month of hire)

•

Step 2: Face-to-face meeting with investigators with direction from Manager/Trainer based on comfort level/knowledge of
employee (should begin no later than second month of hire)

•

Step 3: Face-to-face meetings done independently. Employee may refer to Manager/Trainer if he/she has questions or needs
assistance. (should begin no later than third month of hire)

AREA NEEDING IMPROVEMENT (SPECIFY)

Level 3 Assessment Answering Questions
PLAN FOR IMPROVEMENT

DEADLINE

NOT

SATISFACTORY

SATISFACTORY

INITIALS
Employee

Trainer

Level 3 Re-Read Material in Levels 1 and 3. Mark the date the materials were
re-read in the space provided in each applicable section.
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Additional Reference Materials (if desired, these may have to be purchased at the employee’s expense):
•

Designing Clinical Research, third edition by Steven B. Hulley, Steven R. Cummings, Warren S. Browner, Deborah G. Grady, and Thomas Newman,
Lippincott Williams & Wilkins (ISBN-13: 978-0-7817-8210-4), www.lww.com

•

Clinical Trials and Human Research: A Practical Guide to Regulatory Compliance by Fay A. Rozovsky and Rodney K. Adams, Jossey-Bass (ISBN: 0-78796570-7), www.josseybass.com

•

Clinical Research Resources: Training and Guidance for Regulatory Compliance series, www.clinicalresources.com

•

The Cartoon Guide to Statistics by Larry Gonick and Woollcott Smith, July 14, 1993, Harper Collins (ISBN: 0-06-273102-5). Also available on www.amazon.com.

•

How to Lie with Statistics by Darrell Huff and Irving Geis, 1992, W.W. Norton & Company, Inc (ISBN 978-0-393-31072-6). Also available at
www.amazo.com

•

The Cartoon Guide to Genetics (Updated Edition) by Larry Gonick and Mark Wheelis, Harper Collins, August 14, 1991 (ISBN: 0-06-273099-1). Also
available on www.amazon.com.
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